Journal of Medical Oncology and Therapeutics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +441518081136

Mini Review - Journal of Medical Oncology and Therapeutics (2021) Volume 6, Issue 6

The oncologists guide to synoptic reporting: A primer, terminology: Safety issues and uniformity.

Alexa Nora*

Department of Oncology, University of Benghazi, Benghazi, Libya

*Corresponding Author:
Alexa Nora
Department of Oncology
University of Benghazi
Benghazi, Libya

Accepted date: November 16, 2021

Visit for more related articles at Journal of Medical Oncology and Therapeutics


Synoptic reporting in tumour pathology is defined by means of completeness in phrases of data elements in addition to a selected, laboratory price-like format. Adoption of synoptic reporting results in more entire reporting of crucial parameters, progressed standardisation of diagnostic criteria and terminology, as well as easier retrieval of records. It is therefore related to an excessive degree of satisfaction among cease users together with surgeons and oncologists and contributes to development of clinical care. Furthermore, synoptic reporting is an important step in the direction of higher levels of information seize, which facilitate data alternate and analysis for best warranty, cancer epidemiology and scientific and basic studies. Increased hobby in and adoption of synoptic reporting on a global degree is inspired via the International Collaboration on Cancer Reporting (ICCR) which publishes freely to be had, proof-based totally datasets for reporting an increasing number of distinct cancer types. These trends pave the route for accelerated destiny utility of synoptic reporting across the complete area of oncologic remedy, wherein it's going to in all likelihood deploy comparable blessings to the ones in pathology. Given that synoptic reporting can be considered the most specific manner available for reporting of clinical findings, it may be anticipated to be critical for the promise of precision remedy to turn out to be actual.

Oncologic pathology

Oncologic pathology reviews have a key function in diagnostic work-up, healing control and submit-healing follow-up of each cancer patient [1].

Given the multidisciplinary of present day oncologic management, it's miles natural that numerous specialists depend upon specific varieties of information. These specialists include, however are not confined to, medical and radiation oncologists, surgeons, diagnostic and interventional radiologists, nuclear remedy physicians and pathologists they. Additional stakeholders consist of cancer registries, medical researchers, bio banking experts and nice managers. Furthermore, its miles more and more mentioned that sufferers call for get admission to their reviews – which in turn can also have an impact on how the information therein ought to be supplied.

It might require nearly supernatural skills from a pathologist to keep a lot of these stakeholders in mind when signing out reviews and to deal with their wishes – or maybe to recognize what all of those truly are within the context of every particular most cancers type, histological subtype, sort of specimen, tumour level, eligibility for (neo-) adjuvant healing procedures, and so on [2].

An additional level of complexity arises from the truth that is insufficient for a pathologist just to explain what they see underneath the microscope: the cut-off for a biomarker to be mentioned as fine or bad may vary depending on the context [3].

For distinct organs there can be subtle differences in the diagnostic standards for vascular invasion or in the definition of involvement of surgical margins. Furthermore, these classifications trade over the years – or there can be competing classifications or definitions at a given time factor. Therefore, even a record given by using the hypothetical near-supernatural pathologist noted above may result in confusion, whilst it remains uncertain what the underlying classifications and criteria had been.


Neither CAP nor ICCR have published specific records on how specific wordings are selected for statistics factors or responses. There are a number of recurrent subject matters, but: while comparing the numerous protocols and their development through the years there's a robust tendency toward uniformity inside and throughout protocols. Positive findings, as an example, are usually said as “gift” in place of “yes” or “tremendous.” Similarly, CAP protocols uniformly use the time period “extra nodal extension” instead of “extracapsular extension.”

Negative findings are normally reported as “now not identified” instead of “absent” alongside the road of the declaration that “absence of proof is not evidence of absence” and acknowledging the perception that in remedy the latter cannot often be supplied. Of notice, biomarkers for which the effective end result reflects the regular state of affairs are pronounced, as an example, as “Intact nuclear expression” versus “Loss of nuclear expression” as opposed to “superb”/“negative.”

Different responses to one information detail are generally designed not to differ simplest via a unmarried word, which is probably by accident unnoticed and thereby invert the meant meaning, e.g., “not identified” in place of “now not present.” Also, there may be an inclination in the direction of some diploma of redundancy, including inside the case of grading, i.e., “G2, fairly differentiated” rather than just “G2.”


Get the App